HeartSciences Net Debt Growth & History (HSCS)
HeartSciences's net debt was −$1.3M for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2026 · Jun 30 | 2026-06-30 | −$1.3M | — | — |
| 2026 · Apr 30 | 2026-04-30 | −$1.4M | −$719,518 | — |
| 2025 | 2025-04-30 | −$665,955 | $4.6M | — |
| 2024 | 2024-04-30 | −$5.3M | −$4.2M | — |
| 2023 | 2023-04-30 | −$1.1M | −$267,305 | — |
| 2022 | 2022-04-30 | −$827,292 | — | — |
HeartSciences quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 · Jun 30 | 2026-06-30 | −$1.3M | — | — |
| Q4 2026 · Apr 30 | 2026-04-30 | −$1.4M | −$719,518 | — |
| Q3 2026 | 2026-01-31 | −$3.1M | −$915,528 | — |
| Q2 2026 | 2025-10-31 | −$1.6M | $2.0M | — |
| Q1 2026 | 2025-07-31 | −$2.4M | $1.4M | — |
| Q4 2025 | 2025-04-30 | −$665,955 | $4.6M | — |
| Q3 2025 | 2025-01-31 | −$2.1M | $4.4M | — |
| Q2 2025 | 2024-10-31 | −$3.6M | −$4.0M | — |
| Q1 2025 | 2024-07-31 | −$3.8M | −$3.8M | — |
| Q4 2024 | 2024-04-30 | −$5.3M | −$4.2M | — |
| Q3 2024 | 2024-01-31 | −$6.5M | −$5.2M | — |
| Q2 2024 | 2023-10-31 | $481,204 | $3.0M | — |
| Q1 2024 | 2023-07-31 | $7,362 | $4.2M | — |
| Q4 2023 | 2023-04-30 | −$1.1M | −$267,305 | — |
| Q3 2023 | 2023-01-31 | −$1.3M | — | — |
| Q2 2023 | 2022-10-31 | −$2.5M | — | — |
| Q1 2023 | 2022-07-31 | −$4.2M | — | — |
| Q4 2022 | 2022-04-30 | −$827,292 | — | — |
HeartSciences net debt trends
Between the periods ended 2022-04-30 and 2026-06-30, HeartSciences's net debt decreased from −$827,292 to −$1.3M, a change of −$514,995. The latest reported quarter, Q4 2026 · Jun 30, shows −$1.3M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗